Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positive Predictive Value of Machine Learning Tools (Audiogene v4.0) for Diagnosing DFNA9 in a Large Series of p.Pro51Ser Variant Carriers in COCH.

NCT04331015 is registered in ClinicalTrials.gov with Jessa Hospital as lead sponsor.

NCT NCT04331015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04331015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positive Predictive Value of Machine Learning Tools (Audiogene v4.0) for Diagnosing DFNA9 in a Large Series of p.Pro51Ser Variant Carriers in COCH.
Lead sponsor
Jessa Hospital
Phase
Observational
Overall status
Completed
Start date
February 1, 2020
Completion date
March 28, 2020
Enrollment
111 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dfna9, sensorineural hearing loss